|
| Status |
Public on Aug 08, 2021 |
| Title |
Genome-wide RNA-seq from GSK-J4-treated lung adenocarcinoma cell lines |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Purpose: The goals of our study were to identify downstream pathway regulated by GSK-J4 in lung adenocarcinoma
Methods: RNAs isolated from GSK-J4-treated or untreated lung adenocarcinoma (HCC827, H23 and A549) were analyzed by using an Illumina Nextseq500
Conclusions: Our study represents the first detailed transcriptomic analysis of effects of GSK-J4 in lung adenocarcinoma.
|
| |
|
| Overall design |
mRNAs prepared from GSK-J4-treated or untreated lung adenocarcinoma cell lines were analyzed in duplicaters by Illumina Nextseq500.
|
| |
|
| Contributor(s) |
Hong B, Kim MY, Roe J |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Aug 08, 2018 |
| Last update date |
Aug 08, 2021 |
| Contact name |
Mi Young Kim |
| E-mail(s) |
miyoungkim@kaist.ac.kr
|
| Organization name |
KAIST
|
| Street address |
Biological science
|
| City |
DaeJeon |
| ZIP/Postal code |
305-701 |
| Country |
South Korea |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (20)
|
|
| This SubSeries is part of SuperSeries: |
| GSE133970 |
Genome-wide assessment of GSK-J4-treated lung adenocarcinoma cell lines |
|
| Relations |
| BioProject |
PRJNA485159 |
| SRA |
SRP156785 |
Less...
More...